Member Info for Laura2022

16th July - new contract with partner Numab

14th July - Trading statement

ahead of expectations for FY25. When compared to the year ended 30 June 2024 (FY24), these unaudited numbers would represent an increase in Total Income of approximately 46%

10th July : integration of PYC platform into global personalosed medical provoder DoseMeRx

1st July - new contract

16th June x 2 biostatistics contracts (first ones from new division)

29th May RNSPhysiomics Awarded Contract Extension

9th May RNSContract Award with New UK Client

17th Apr Physiomics Awarded New Contract

16th Apr RNS-R Publication of Peer Reviewed Article

15th Apr new contract

17th Mar RNS Contract Award with new client

OSD

As has been mentioned several times , thats often due to client request OR if repeat business

Physiomics Awarded New Contract by Numab Therapeutics

Physiomics plc (AIM: PYC), a leading mathematical modelling, data science and biostatistics company supporting the development of new therapeutics and personalised medicine solutions, is pleased to announce a new contract with its valued and long-standing client, Numab Therapeutics AG.

And looking at account, yet another pretty dormant account since 2020 (ZOE) amd the n just appears on MET1 in June 2205

:)

75 posts on MET1 and most contradict each other depending on the share price

Another filtered

Make your mind up

Jbatch

Posted in: MET1

Posts: 712

Price: 25.50

No Opinion

RE: Friday profit taking11 Jul 2025 18:04

Absolutely, and I was one at the top price. Probably have a couple of days of falls next week for profit taking and absorb new shares and will probably start rising again, just hope it drops to around 20 but thinks maybe it won't get that far.

Below

These are the 6mths results for OBD

FINANCIAL HIGHLIGHTS

•

Revenue of £587k (H1 2024: £327k)

•

Operating loss £5.88m (H1 2024: £5.99m)

Ps Worst

You must not have read the update this week, as PYC are not just a "consultancy" company

Worst

PYC are closer than most for profit while OBD has spent £5mln+ per year to get this far and PYC still has higher revenues

Go figure

Peter Sargent

Chief Executive Officer at Physiomics Plc

6h

I am really excited about expanding this partnership and continuing to work with the fantastic DoseMe team. This is not only a positive step forward for Physiomics' current Personalised Medicine Dosing software, but brings a deeper collaboration in the development of dosing software for new therapies and indications. Optimising treatment for each individual to improve patient outcomes!

#Physiomics #PersonalisedMedicine #DoseMe

It's been very very quiet on AIM last week or so , particularly as the bitcoin treasury euphoria (bubble) has disappeared, therefore those stunning PYC figures fell on a slightly deaf market, but i believe more news is coming judging by how busy our various areas of focus are

Thanks 2phev

On again

Back in at 15.3p

Hopefully anther good trade

Hope no one fell for your "financial " courses you were offering

Charltan at best

Was a dubious series of events Dr Jan

OSD

This news bodes well for PYC A.I cancer dosing app both with Beyond Blood and with US based DoseMeRx

The blood test being developed with PYC and Beyond Blood could well get similar endorse as OBD and far cheaper

Miton have been selling across AIM since Jan so maybe Miton nearly gone .

That £44k looks like a sell ?